Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of Head”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05576974
What this trial is testing

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Who this might be right for
Head and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma
University of Texas Southwestern Medical Center 120
Testing effectiveness (Phase 2)Ended earlyNCT04633278
What this trial is testing

CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Regeneron Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT03620123
What this trial is testing

Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck

Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous Cell of Head and Neck
AIO-Studien-gGmbH 54
Not applicableStudy completedNCT05942794
What this trial is testing

Identification of Oral Lesions Through an Autofluorescence System

Who this might be right for
Oral LeukoplakiaAutofluorescenceSecondary Prevention+4 more
Federico II University 200
Testing effectiveness (Phase 2)Study completedNCT05323656
What this trial is testing

Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Calliditas Therapeutics Suisse SA 55
Testing effectiveness (Phase 2)Study completedNCT00084682
What this trial is testing

Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Stage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral Cavity+1 more
National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)Looking for participantsNCT07554456
What this trial is testing

BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 90
Testing effectiveness (Phase 2)WithdrawnNCT04987996
What this trial is testing

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Who this might be right for
Metastatic MelanomaHead and Neck Squamous Cell Carcinoma
Providence Health & Services
Testing effectiveness (Phase 2)Ended earlyNCT03020823
What this trial is testing

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
SynCore Biotechnology Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Study completedNCT00006361
What this trial is testing

SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck

Who this might be right for
Carcinoma of Unknown PrimaryHead and Neck CancerNon-melanomatous Skin Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03789097
What this trial is testing

Vaccination With Flt3L, Radiation, and Poly-ICLC

Who this might be right for
Non-Hodgkin's LymphomaMetastatic Breast CancerHead and Neck Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 17
Not applicableStudy completedNCT02892786
What this trial is testing

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Institut de Cancérologie de Lorraine 40
Early research (Phase 1)Study completedNCT01872923
What this trial is testing

Dose Escalating Study for Amphinex-based PCI of Bleomycin.

Who this might be right for
Cutaneous or Sub-cutaneous Malignancies
PCI Biotech AS 3
Testing effectiveness (Phase 2)Ended earlyNCT03646461
What this trial is testing

Trial of Ibrutinib Combined With Nivolumab or Cetuximab to Treat Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of the Head and Neck
University of California, San Diego 5
Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Testing effectiveness (Phase 2)Study completedNCT03691714
What this trial is testing

Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck CancerHead and Neck CancerHead and Neck Neoplasms+1 more
University of Cincinnati 35
Testing effectiveness (Phase 2)Ended earlyNCT04862455
What this trial is testing

NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center 14
Not applicableWithdrawnNCT06603155
What this trial is testing

Time Restricted Eating (TRE) in Metastatic Head and Neck Squamous Cell Cancer (mHNSCC) or Unresectable or Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic Head-and-neck Squamous-cell CarcinomaUnresectable Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Duke University
Early research (Phase 1)Ended earlyNCT00443261
What this trial is testing

Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma
University of Kansas Medical Center 1
Next Page